Arena Pharma (ARNA) Volatility Elevated, Shares Higher After Close of $70M Offering
Tweet Send to a Friend
Up)
Arena Pharmaceuticals (Nasdaq: ARNA) shares are drawing some attention Tuesday following the announcement late Monday underwriters on its 12.65 million offering exercised the full over-allotment of 1.65 million shares, for a total gross sale of $69.6 million.
Implied volatility is 5 percent above Monday's close with Arena currently at 43.8 percent of its trailing annual average.
Shares are 5 percent higher on the session.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Implied volatility is 5 percent above Monday's close with Arena currently at 43.8 percent of its trailing annual average.
Shares are 5 percent higher on the session.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Friday's Hot IPOs Get Even Hotter (MKTO) (DATA)
- Tesla Motors (TSLA) filed an automatic shelf registration
- UPDATE: Kansas City Southern (KSU) to Replace Dean Foods (DF) in S&P 500; WhiteWave Foods (WWAV) to S&P MidCap 400
Create E-mail Alert Related Categories
Equity Offerings, Momentum Movers, OptionsRelated Entities
Options
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
